Pomalidomide plus low-dose dexamethasone (POM plus LoDEX) versus high-dose dexamethasone (HiDEX) in relapsed/refractory multiple myeloma (RRMM): Impact of cytogenetics in MM-003

被引：0
|
作者：
Goldschmidt, Hartmut
Dimopoulos, Meletios A.
Weisel, Katja C.
Moreau, Philippe
Lacy, Martha
Song, Kevin W.
Delforge, Michel
Karlin, Lionel
Banos, Anne
Rocafiguera, Albert Oriol
Yu, Xin
Sternas, Lars
Jacques, Christian
Zaki, Mohamed H.
San-Miguel, Jesus F.
机构：
[1] Univ Klinikum Heidelberg, Heidelberg, Germany
[2] Alexandra Hosp, Athens, Greece
[3] Univ Tubingen Hosp, Dept Med, Tubingen, Germany
[4] Hop Hotel Dieu, Univ Hosp, Nantes, France
[5] Mayo Clin, Rochester, MN USA
[6] Vancouver Gen Hosp, Vancouver, BC, Canada
[7] Katholieke Univ Leuven Hosp, Dept Hematol, Louvain, Belgium
[8] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Pierre Benite, France
[9] Ctr Hosp Cote Basque, Bayonne, France
[10] HGTiP, Inst Catala Oncol, Barcelona, Spain
[11] Celgene Corp, Summit, NJ USA
[12] Hosp Univ Salamanca, Salamanca, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8528
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pomalidomide (CC4047) plus Low-Dose Dexamethasone (Pom/Dex) as Therapy for Relapsed Multiple Myeloma
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Gertz, Morie A.
    Dispenzieri, Angela
    Zeldenrust, Stephen R.
    Kumar, Shaji
    Greipp, Philip R.
    Lust, John A.
    Russell, Stephen J.
    Buadi, Francis
    Kyle, Robert A.
    Fonseca, Rafael
    Bergsagel, P. Leif
    Roy, Vivek
    Mikhael, Joseph R.
    Stewart, A. Keith
    Allred, Jacob B.
    Laumann, Kristina
    Thompson, Melanie
    Mandrekar, Sumithra J.
    Rajkumar, S. Vincent
    Dingli, David
    Reeder, Craig
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S46 - S47
  • [42] Pomalidomide plus low-dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure
    Siegel, David S.
    Schiller, Gary J.
    Song, Kevin W.
    Agajanian, Richy
    Stockerl-Goldstein, Keith
    Kaya, Hakan
    Sebag, Michael
    Samaras, Christy
    Malek, Ehsan
    Talamo, Giampaolo
    Seet, Christopher S.
    Mouro, Jorge
    Pierceall, William E.
    Zafar, Faiza
    Chung, Weiyuan
    Srinivasan, Shankar
    Agarwal, Amit
    Bahlis, Nizar J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : 501 - 510
  • [43] Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma
    Badros, Ashraf
    Hyjek, Elizabeth
    Ma, Ning
    Lesokhin, Alexander
    Dogan, Ahmet
    Rapoport, Aaron P.
    Kocoglu, Mehmet
    Lederer, Emily
    Philip, Sunita
    Milliron, Todd
    Dell, Cameron
    Goloubeva, Olga
    Singh, Zeba
    BLOOD, 2017, 130 (10) : 1189 - 1197
  • [44] MM-007: A phase 3 trial comparing the efficacy and safety of pomalidomide (POM), bortezomib (BORT), and low-dose dexamethasone (LoDEX [PVD]) versus BORT and LoDEX (VD) in subjects with relapsed or refractory multiple myeloma (RRMM).
    Richardson, Paul G.
    Bensmaine, Amine
    Doerr, Thomas
    Wang, Jianming
    Zaki, Mohamed H.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] Selinexor Plus Pomalidomide and Low Dose Dexamethasone (SPd) in Patients with Relapsed or Refractory Multiple Myeloma
    Chen, Christine I.
    Sutherland, Heather J.
    Kotb, Rami
    Sebag, Michael
    White, Darrell J.
    Bensinger, William
    Gasparetto, Cristina J.
    Leblanc, Richard
    Venner, Christopher P.
    Lentzsch, Suzanne
    Schiller, Gary J.
    Lipe, Brea
    Del Col, Aldo
    Shah, Jatin J.
    Jeha, Jacqueline
    Saint-Martin, Jean-Richard
    Kauffman, Michael G.
    Shacham, Sharon
    Bahlis, Nizar
    BLOOD, 2018, 132
  • [46] A STATISTICAL COMPARISON OF THE EFFICACY AND SAFETY OF LOW-DOSE LENALIDOMIDE plus LOW- DOSE DEXAMETHASONE WITH FULL-DOSE LENALIDOMIDE plus DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
    Quach, H.
    Fernyhough, L.
    Henderson, R.
    Corbett, G.
    Honemann, D.
    Blacklock, H.
    Browett, P.
    Link, E.
    Cowan, L.
    Li, J.
    Swern, A.
    Hussein, M.
    Lynch, K.
    Dimopoulos, M.
    Prince, M.
    HAEMATOLOGICA, 2012, 97 : 350 - 351
  • [47] A PHASE IB STUDY OF ISATUXIMAB PLUS POMALIDOMIDE (POM) AND DEXAMETHASONE (DEX) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
    Mikhael, J.
    Richardson, P.
    Usmani, S.
    Raje, N.
    Bensinger, W.
    Kanagavel, D.
    Gao, L.
    Ziti-ljajic, S.
    Anderson, K.
    HAEMATOLOGICA, 2017, 102 : 168 - 168
  • [48] Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
    Richardson, Paul G.
    Perrot, Aurore
    San-Miguel, Jesus
    Beksac, Meral
    Spicka, Ivan
    Leleu, Xavier
    Schjesvold, Fredrik
    Moreau, Philippe
    Dimopoulos, Meletios A.
    Huang, Jeffrey Shang-Yi
    Minarik, Jiri
    Cavo, Michele
    Prince, H. Miles
    Malinge, Laure
    Dubin, Franck
    van de Velde, Helgi
    Anderson, Kenneth C.
    LANCET ONCOLOGY, 2022, 23 (03): : 416 - 427
  • [49] Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study
    Attal, Michel
    Richardson, Paul G.
    Rajkumar, S. Vincent
    San-Miguel, Jesus
    Beksac, Meral
    Spicka, Ivan
    Leleu, Xavier
    Schjesvold, Fredrik
    Moreau, Philippe
    Dimopoulos, Meletios A.
    Huang, Jeffrey Shang-Yi
    Minarik, Jiri
    Cavo, Michele
    Prince, H. Miles
    Mace, Sandrine
    Corzo, Kathryn P.
    Campana, Frank
    Le-Guennec, Solenn
    Dubin, Franck
    Anderson, Kenneth C.
    LANCET, 2019, 394 (10214): : 2096 - 2107
  • [50] MM-013 Phase 2, Multicenter Study of Pomalidomide (POM) Plus Low -Dose Dexamethasone (LoDEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI): Pharmacokinetics (PK) Analysis
    Sonneveld, Pieter
    Weisel, Katja C.
    Li, Yan
    Kueenburg, Elisabeth
    Collins, Shona
    Di Micco, Antonia
    Rosettani, Barbara
    Bacon, Pamela
    Dimopoulos, Meletios A.
    BLOOD, 2017, 130
12345